| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 67,436 | 64,875 | 68,351 | 100,154 | | Cost of Revenue | 16,019 | 17,472 | 16,972 | 20,610 | | | Gross Profit | 51,417 | 47,403 | 51,379 | 79,544 | | | Operating Expenses | | Research Development | (144) | 144 |
-
|
-
| | Selling General and Administrative | 8,689 | 9,051 | 9,819 | 11,938 | | Non Recurring | 486 |
-
|
-
| 922 | | Others | 53,933 | 50,796 | 47,272 | 50,309 | | | | Total Operating Expenses | 62,964 |
-
|
-
|
-
| | | | Operating Income or Loss | (11,547) | (12,588) | (5,712) | 16,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 26 | 39 | 85 | (162,056) | | Earnings Before Interest And Taxes | (11,521) | (12,549) | (5,627) | (145,681) | | Interest Expense | 3,244 | 2,901 | 2,162 | 2,088 | | Income Before Tax | (14,765) | (15,450) | (7,789) | (147,769) | | Income Tax Expense | (2,193) | (3,975) | (2,132) | (51,392) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,572) | (11,475) | (5,657) | (96,377) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,572) | (11,475) | (5,657) | (96,377) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,572) | ($11,475) | ($5,657) | ($96,377) |
|
0.16% Nasdaq 
Income Statement
